Cemat A/S
25.2.2021 14:33:23 CET | Globenewswire | Press release
Nasdaq Copenhagen
Nikolaj Plads 6
DK-1067 Copenhagen K
Copenhagen, 25 February 2021
ANNOUNCEMENT no 3/2021
Managers’ transactions
Pursuant to Article 19 of the market abuse regulation Cemat A/S hereby announces the following information received 24 February 2021.
| Name: | Jarosław Lipiński |
| Reason for filing: | Insider |
| Company name: | Cemat A/S |
| Identification code and name: | ISIN DK0010271584 |
| Transaction type: | Purchase |
| Date: | 23 February 2021 |
| Market: | Nasdaq Copenhagen |
| Number of traded shares: | 495,000 |
| Price: | 0.394594 |
Cemat A/S
Frede Clausen
Chairman
This announcement has been prepared in a Danish-language and an English-language
version. In case of doubt, the Danish version prevails.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Marimekko Corporation22.9.2026 16:15:00 CEST | Press release
Marimekko and VEJA announce limited-edition collaboration collection launching in November 2026
ASM International NV22.9.2026 16:00:00 CEST | Press release
ASM launches breakthrough Flowable Carbon technology for the next era of semiconductor scaling
Alm. Brand A/S22.9.2026 15:46:09 CEST | Press release
Alm. Brand Tier-2 Bonds
SK pharmteco Inc.22.9.2026 15:03:00 CEST | Press release
SK pharmteco and GEMMABio Expand Rare Disease Manufacturing Collaboration Following Important Spinal Muscular Atrophy (SMA) Clinical Trial Milestone
Tenneco22.9.2026 15:00:53 CEST | Press release
Tenneco to Showcase Latest Railway Braking, Sliding Bearing and Systems Protection Solutions at InnoTrans 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
